United Kingdom Prefilled Syringes Market Size, Share, and COVID-19 Impact Analysis, By Type (Disposable and Reusable), By Material (Glass and Plastic), and UK Prefilled Syringes Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Prefilled Syringes Market Forecasts to 2035

• The United Kingdom Prefilled Syringes Market Size Was Estimated at USD 483.5 Million in 2024
• The UK Prefilled Syringes Market Size is Expected to Grow at a CAGR of around 8.47% from 2025 to 2035
• The UK Prefilled Syringes Market Size is Expected to Reach USD 1182.4 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the UK Prefilled Syringes Market Size is Anticipated to Reach USD 1182.4 Million by 2035, Growing at a CAGR of 8.47% from 2025 to 2035. Growing acceptance of self-injection devices, the incidence of chronic diseases, and technical improvements are some of the factors propelling the market's expansion.

Market Overview

The UK prefilled syringes market involves producing and distributing single-use syringes pre-filled with exact medication doses, providing a convenient, ready-to-use alternative that eliminates manual filling, enhances safety, and ensures accurate dosing for medical treatments and vaccinations. The growth in the UK prefilled syringe market is being propelled by increasing demand for biologics and biosimilars, as well as a shift toward home healthcare and self-administration of therapy for chronic conditions such as diabetes and autoimmune conditions. Greater growth due to the increase in elderly people. Due to biologic medicines, like therapeutic vaccinations, being safer, more effective, with fewer side effects compared to traditional treatments have gained in popularity. The increase in biologics has also elevated the demand for sophisticated, reliable packaging solutions, like prefilled syringes, which help maintain drug stability and potency. The segment's growth is primarily driven by the introduction of new products, technological developments, and the increasing use of prefilled syringes. For example, Novo Nordisk's smart insulin pens were first made available to patients getting diabetes treatment through the National Health Service (NHS) in March 2022. This marked the first time that such devices were able to collect and track dosage information. The growth of the prefilled syringes market in the UK is being driven by the advancement of biological therapies.

Report Coverage

This research report categorizes the market for the UK prefilled syringes market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom prefilled syringes market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom prefilled syringes market.

Driving Factors

The UK prefilled syringes market is predominantly driven by a shift from glass vials to single-use, easy-to-use syringe devices; an increase in the prevalence of chronic diseases such as diabetes and arthritis; and the need for safe, easy drug delivery. Technological innovations such as Bluetooth/Wi-Fi auto-injectors and precise medicine dosage improve patient safety and compliance. The need for prefilled syringes has also been accelerated by the increase in vaccines produced in response to COVID-19 in the pharmaceutical and healthcare sectors, as well as reducing the risk of needlestick injuries.

Restraining Factors

Many prefilled syringe suppliers in the UK are experiencing slower growth due to high production and compliance costs, strict regulations, and the availability of cheaper alternatives, for example, standard vials and ampoules. Issues around medication stability in storage and low awareness in specific markets may also hold back the sector as a whole. These factors hamper the prefilled syringes market during the forecast period.

Market Segmentation

The United Kingdom prefilled syringes market share is classified into type and material.

• The disposable segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom prefilled syringes market is segmented by type into disposable and reusable. Among these, the disposable segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The disposable syringes, it is now much simpler to reduce the risk to some degree by discarding the needle right away after use to prevent cross-contamination. Since disposable prefilled syringes are necessary for testing and medicine administration, they are needed for the majority of chronic disease diagnostic and treatment strategies, which increases demand for the product.

• The glass segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom prefilled syringes market is segmented by material into glass and plastic. Among these, the glass segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Glass provides a solid barrier against light, oxygen, and moisture from the exterior. This is important for stabilizing the medication over time and preventing degradation. For some pharmaceuticals, especially those sensitive to specific environmental conditions, having great barrier properties may not be enough since plastics might not protect the pharmaceutical, while glass is best. Additionally, glass syringes have good clarity, helping medical professionals to see what is in the syringe.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom prefilled syringes market and a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Owen Mumford
• GSK (GlaxoSmithKline)
• Becton, Dickinson and Company (BD)
• Gerresheimer
• SCHOTT Pharma
• Terumo
• West Pharmaceutical Services
• Catalent
• Stevanato Group
• Baxter International Inc.
• Nipro Corporation
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom prefilled syringes market based on the below-mentioned segments:

United Kingdom Prefilled Syringes Market, By Type

• Disposable
• Reusable

United Kingdom Prefilled Syringes Market, By Material

• Glass
• Plastic